October 2017

Extended partnership between Radiomedix Inc and ITM´s subsidiary ITG for exclusive distribution of n.c.a Lutetium-177 in North America

2017-10-23T16:25:12+00:00October 10th, 2017|Press Release, Products, Recent News|

RadioMedix INC, a biotechnological company, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer, and ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced they have signed an exclusive [...]

August 2016